Clonal hematopoiesis in frequent blood donors, immune microenvironment and bispecific antibody response in diffuse large B-cell lymphoma, and blinatumomab as part of early consolidation therapy in CD19-positive Ph-negative B-cell acute lymphoblastic lymphoma
This episode covers clonal hematopoiesis in frequent blood donors, the immune microenvironment's role in diffuse large B-cell lymphoma response to bispecific antibodies, and the use of blinatumomab in treating B-cell acute lymphoblastic lymphoma.